Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension

Author(s):  Allen Loyd V Jr

Issue:  Nov/Dec 2019 - Volume 23, Number 6
View All Articles in Issue

Page(s):  488

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, formulation, pregabalin, gabapentinoid, voltage-dependent calcium channel inhibitor, anticonvulsant agent, seizure disorder, neuropathic pain, muscle pain, fibromyalgia, pain relief

Related Categories: EXCIPIENTS, FORMULATIONS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 488

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 486

Compounded Pain Formulations: What is the Evidence?
Asbill Scott
, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014
Pg. 278-286

Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
May/Jun 2010
Pg. 200-203

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah
, Agu Remigius U
Nov/Dec 2019
Pg. 496-503

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Clinical Nuggets and Pearls: Chronic Neuropathic Pain and Opioid Tolerance
Jones Marty
Jan/Feb 2002
Pg. 4-6

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
Nov/Dec 2019
Pg. 494

Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie
, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Mar/Apr 2015
Pg. 167-173

The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
May/Jun 2010
Pg. 193-199

Chronic Neuropathic Pain: Pharmacological Interventions in New Millennium
Jones Marty
Jan/Feb 2000
Pg. 6-15

Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin
, Carvalho Maria, Banov Fabiana
Nov/Dec 2023
Pg. 468-473

Topical Treatment of Neuropathic Pain
Vadaurri Vince
May/Jun 2008
Pg. 182-190

Update on Managing Neuropathic Pain
McNulty Jack P
, Muller George
May/Jun 2009
Pg. 182-190

Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jul/Aug 2015
Pg. 295-300

Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
Jan/Feb 2014
Pg. 14-19

Return to Top